Sitero

Sitero

Sitero operates as a technology-enabled clinical research partner, serving more than 200 pharmaceutical, biotech, and institutional research organizations worldwide. The firm was founded with the mission of offering accessible clinical trial solutions for life-sciences companies of all sizes, drawing on a founding team with extensive industry experience and a deep bench of subject-matter experts. Core service lines include Clinical Services, Drug Safety, and IRB Ethical Review, alongside a proprietary suite of eClinical technology called Mentor. The firm’s technology stack includes Mentor EDC, RTSM, CTMS/eTMF, eConsent, and payment modules for sites and participants. These tools support its clinical operations, which the firm says can activate studies 25% faster than industry-standard startup times. Sitero’s geographic footprint spans the United States, the United Kingdom, and India, with corporate headquarters in Coral Gables, Florida. The firm also maintains a Biosafety/IBC practice that partners with institutions and clinical sites on worker and community safety. Sitero’s team operates across three offices internationally, with corporate phone lines for the US, UK, and India. In September 2026, Sitero will exhibit at Outsourcing Clinical Trials Southern California and SCDM US in Raleigh, per its public events calendar. The firm also lists a flat-fee IRB model, which it presents as a structural departure from traditional competitor pricing. What distinguishes Sitero is its hybrid model: it is not a pure CRO or a standalone software vendor, but an integrated services-and-platform company. By housing clinical operations, regulatory review, drug safety, and software development under one roof, the firm aims to reduce the friction that arises when sponsors manage separate vendors for each function.